Trade

with

Zoetis Inc
(NYSE: ZTS)
AdChoices
36.58
+0.47
+1.30%
After Hours :
36.58
0.00
0.00%

Open

36.20

Previous Close

36.11

Volume (Avg)

1.42M (3.27M)

Day's Range

36.10-36.60

52Wk Range

28.14-37.97

Market Cap.

18.10B

Dividend Rate (Yield )

0.29 (0.78%)

Beta

-

Shares Outstanding

501.19M

P/E Ratio (EPS)

34.36 (1.05)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 4.56B

    • Net Income

    • 504.00M

    • Market Cap.

    • 18.10B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 11.43

    • PEG (Price/Earnings Growth) Ratio

    • 2.54

    • Beta

    • -

    • Forward P/E

    • 21.14

    • Price/Sales

    • 3.97

    • Price/Book Value

    • 14.56

    • Price/Cash flow

    • 32.36

      • EBITDA

      • 1.00B

      • Return on Capital %

      • 8.25

      • Return on Equity %

      • 51.17

      • Return on Assets %

      • 8.25

      • Book Value/Share

      • 2.51

      • Shares Outstanding

      • 501.19M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.07 (11/3/2014)

      • Dividend Declaration Date

      • 10/2/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 24.00

        • Credit Rating

        • BBB+

        • Analysts

        • 3

        • EPS Estimate

        • 1.59

        • Cashflow Estimate

        • 1.93

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 3.90

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • 15.60

          • -26.33

          • Net Income

            Q/Q (last year)

          • 6.30

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 64.38

            • 64.72

            • Pre-Tax Margin

            • 16.00

            • 13.77

            • Net Profit Margin

            • 11.43

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 61.80

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 8.10

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 5.30

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 2.89

              • 0.33

              • Current Ratio

              • 3.14

              • 1.52

              • Quick Ratio

              • 1.58

              • 0.87

              • Interest Coverage

              • -

              • 6.77

              • Leverage Ratio

              • 5.18

              • 1.91

              • Book Value/Share

              • 2.51

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 33.67

                • 65.79

                • P/E Ratio 5-Year High

                • 36.08

                • 237.47

                • P/E Ratio 5-Year Low

                • 26.74

                • 19.71

                • Price/Sales Ratio

                • 3.84

                • 3.69

                • Price/Book Value

                • 14.08

                • 3.46

                • Price/Cash Flow Ratio

                • 32.36

                • 22.12

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 51.17

                    (-)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 8.25

                    (-)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 11.25

                    (-)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 53.78k

                  • 27.79k

                  • Inventory Turnover

                  • 1.27

                  • 1.80

                  • Asset Turnover

                  • 0.72

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  794.00M
                  Operating Margin
                  17.41
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  32.36
                  Ownership

                  Institutional Ownership

                  92.66%

                  Top 10 Institutions

                  41.82%

                  Mutual Fund Ownership

                  46.57%

                  Float

                  99.99%

                  5% / Insider Ownership

                  0.02%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Wellington™

                  •  

                    11,873,396

                  • 0.00

                  • 2.37

                  • Vanguard Health Care Fund

                  •  

                    10,798,417

                  • 3.61

                  • 2.16

                  • Vanguard Windsor™ II Fund

                  •  

                    10,753,890

                  • 10.86

                  • 2.15

                  • Vanguard Total Stock Mkt Idx

                  •  

                    8,141,497

                  • 0.34

                  • 1.62

                  • T. Rowe Price Capital Appreciation Fund

                  •  

                    6,923,200

                  • 28.51

                  • 1.38

                  • MainStay Large Cap Growth Fund

                  •  

                    5,268,100

                  • -8.69

                  • 1.05

                  • Vanguard Five Hundred Index Fund

                  •  

                    5,203,298

                  • 0.27

                  • 1.04

                  • BBH Core Select Fund

                  •  

                    5,132,137

                  • 0.00

                  • 1.02

                  • Vanguard Institutional Index Fund

                  •  

                    5,077,204

                  • -1.04

                  • 1.01

                  • SPDR® S&P 500 ETF

                  •  

                    4,951,427

                  • 1.44

                  • 0.97

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    42,029,947

                  • +9.33%

                  • 8.39

                  • Vanguard Group, Inc.

                  •  

                    25,995,640

                  • +2.92%

                  • 5.19

                  • Lazard Asset Management LLC

                  •  

                    22,529,823

                  • +20.03%

                  • 4.50

                  • State Street Corp

                  •  

                    20,736,422

                  • +1.03%

                  • 4.14

                  • Brown Brothers Harriman & Co

                  •  

                    20,443,020

                  • +20.39%

                  • 4.08

                  • T. Rowe Price Associates, Inc.

                  •  

                    20,041,574

                  • +53.13%

                  • 4.00

                  • State Farm Mutual Automobile Ins CO

                  •  

                    19,124,444

                  • 0.00%

                  • 3.82

                  • BlackRock Fund Advisors

                  •  

                    14,796,468

                  • -0.66%

                  • 2.95

                  • MFS Investment Management K.K.

                  •  

                    12,324,397

                  • +4.88%

                  • 2.46

                  • Carmignac Gestion

                  •  

                    11,484,628

                  • -8.51%

                  • 2.29

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Aggressive Growth

                  Style

                  Large Growth

                  Zoetis Inc was incorporated in Delaware in July 2012. It is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. It ma...morerkets products across four regions: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific; eight core species: the livestock species of cattle, swine, poultry, sheep and fish, and the companion animal species of dogs, cats and horses; and five product categories: anti-infectives - products that prevent, kill or slow the growth of bacteria, fungi or protozoa; vaccines - biological preparations that help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response; parasiticides - products ...morethat prevent or eliminate external and internal parasites such as fleas, ticks and worms; medicated feed additives; and other pharmaceutical products - pain and sedation, oncology, antiemetic, allergy and dermatology; and reproductive products. The Company organizes and operates its business in four segments: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific. The Company sells its livestock products directly to a diverse set of livestock producers, including beef and dairy farmers as well as pork, poultry and aquaculture operations, and to veterinarians, third-party veterinary distributors and retail outlets that typically then sell the products to livestock producers. It primarily sells its companion animal products to veterinarians or to third-party veterinary distributors that typically then sell its products to veterinarians, and in each case veterinarians then typically sell its products to pet owners. Its primary competitors include animal health medicines and vaccines companies such as Merck Animal Health, the animal health division of Merck & Co., Inc. (formerly known as Intervet/Schering-Plough); Merial, the animal health division of Sanofi S.A.; Elanco, the animal health division of Eli Lilly and Company; Bayer Animal Health, the animal health division of Bayer AG; Novartis Animal Health, the animal health division of Novartis AG; and Boehringer Ingelheim Animal Health, the animal health division of Boehringer Ingelheim GmbH. In addition, it competes with hundreds of other animal health product producers throughout the world.lessless

                  Key People

                  Mr. Juan Ramon Alaix

                  Director/CEO

                  Mr. Michael B. McCallister

                  Chairman of the Board/Director

                  Paul S. Herendeen

                  CFO/Executive VP

                  Kristin C. Peck

                  Executive VP/President, Divisional

                  Catherine A. Knupp

                  Executive VP/President, Divisional

                  • Zoetis Inc

                  • 100 Campus Drive

                  • Florham Park, NJ 07932

                  • USA.Map

                  • Phone: +1 973 822-7000

                  • Fax: -

                  • zoetis.com

                  Incorporated

                  2012

                  Employees

                  9,800

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: